<DOC>
	<DOC>NCT01840319</DOC>
	<brief_summary>The goal of this retrospective observational study is to collect only status survival data 30 days after the last dose of treatment of patients included in the initial protocol WYETH 3074A1-4448 / B1811030. The purpose is to estimate the survival status, 30 days after the last intake of tigecycline to patients hospitalized in ICU and treated by tigecycline.</brief_summary>
	<brief_title>Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)</brief_title>
	<detailed_description />
	<criteria>All patients included in the previous study WYETH 3074A14448 then Pfizer B1811030 for which mortality status was not known at the closure of this previous study Patients who has withdrawn their consent for the study WYETH3074A14448 then Pfizer B1811030.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>